HealthRevolution
Staff -
September 20, 2023
The Federal Trade Commission, with the support of the Food and Drug Administration, is warning pharmaceuticals not to unfairly try to block generic drug makers.
According to the FTC, some pharmaceuticals "improperly list patents in the FDA’s catalog of 'Approved Drug Products with Therapeutic Equivalence Evaluations,'' commonly known as the 'Orange Book.'" Such behavi...